Scientist working in lab with purple gloves

Novartis Financial Results – Q1 2023

Novartis announced the company’s financial results for the first quarter of 2023.
Man at riverbank

Novartis 2022 Annual Report

Explore the Novartis in Society Integrated Report 2022 and Annual Report 2022 on our Reporting Hub.
Woman scientist in a lab

Novartis in the US

We invite you to learn more about Novartis and our impact on patients, families and their communities.

Learn more
Woman scientist in lab

About Novartis

We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Patient smiling at doctor image

Patients and Caregivers

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives.
Young boy wearing stethoscope

The Novartis Commitment to Patients and Caregivers

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives.
Medical students

Beacon of Hope

Novartis is expanding the Beacon of Hope program through alliances with Historically Black Medical Schools to address systemic health disparities.

Learn more
tree roots with green leaves stripe mage_0

Addressing health inequities starts by looking within

The Novartis US Foundation has partnered with the Institute for Healthcare Improvement to help healthcare systems better serve patients.
us careers image_0

Careers

769 million lives touched by our products. Join us.

Latest News

Jun 08, 2023

Novartis premieres powerful new docuseries at Tribeca Festival to shine a light on debilitating skin disease

Jun 02, 2023

Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups

Apr 20, 2023

Novartis presents new five-year data on disability outcomes and safety of Kesimpta® (ofatumumab) in people living with relapsing multiple sclerosis
View more